Kwok, Hui Si http://orcid.org/0000-0002-2858-8876
Freedy, Allyson M. http://orcid.org/0000-0002-2953-8133
Siegenfeld, Allison P. http://orcid.org/0000-0001-8599-577X
Morriss, Julia W. http://orcid.org/0000-0002-7337-8712
Waterbury, Amanda L. http://orcid.org/0000-0002-4473-2866
Kissler, Stephen M.
Liau, Brian B. http://orcid.org/0000-0002-2985-462X
Funding for this research was provided by:
Charles A. King Trust (No award number)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (T32GM007753, 1DP2GM137494)
Harvard University (Startup funds)
American Cancer Society (RSG-22-083-01-DMC)
Article History
Received: 13 July 2022
Accepted: 23 February 2023
First Online: 27 March 2023
Competing interests
: B.B.L. holds a sponsored research project with AstraZeneca, is a scientific consultant for Imago BioSciences and Exo Therapeutics and is a shareholder and member of the scientific advisory board of Light Horse Therapeutics. The other authors declare no competing interests.